FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

870523005: Bempedoic acid (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3969937013 Bempedoic acid (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3969938015 Bempedoic acid en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bempedoic acid Is a Long chain fatty acid true Inferred relationship Existential restriction modifier
Bempedoic acid Is a Antilipemic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bempedoic Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 1
Product containing bempedoic acid in oral dose form (medicinal product form) Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 1
Product containing only bempedoic acid in oral dose form (medicinal product form) Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 1
Product containing bempedoic acid (medicinal product) Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 1
Product containing precisely bempedoic acid 180 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Bempedoic acid Inferred relationship Existential restriction modifier 1
Product containing precisely bempedoic acid 180 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 1
Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 2
Product containing precisely bempedoic acid 180 milligram and ezetimibe 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Bempedoic acid Inferred relationship Existential restriction modifier 2
Product containing bempedoic acid and ezetimibe (medicinal product) Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 2
Bempedoic + Ezetimibe Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 2
Product containing bempedoic acid and ezetimibe in oral dose form (medicinal product form) Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 2
Product containing only bempedoic acid and ezetimibe in oral dose form (medicinal product form) Has active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier 2
Adverse reaction to bempedoic acid Causative agent True Bempedoic acid Inferred relationship Existential restriction modifier 1
Allergy to bempedoic acid Causative agent True Bempedoic acid Inferred relationship Existential restriction modifier 1
Bempedoic acid 180mg tablets 28 tablet Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Bempedoic acid 180mg tablets Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Nustendi 180mg/10mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Nustendi 180mg/10mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier
Bempedoic acid 180mg / Ezetimibe 10mg tablets 28 tablet Has specific active ingredient True Bempedoic acid Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start